Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Viemed Healthcare (VMD) Net Margin (2018 - 2025)

Viemed Healthcare's Net Margin history spans 8 years, with the latest figure at 7.63% for Q4 2025.

  • For Q4 2025, Net Margin rose 35.0% year-over-year to 7.63%; the TTM value through Dec 2025 reached 5.69%, up 60.0%, while the annual FY2025 figure was 5.69%, 60.0% up from the prior year.
  • Net Margin reached 7.63% in Q4 2025 per VMD's latest filing, up from 5.01% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 12.79% in Q4 2021 to a low of 2.69% in Q2 2024.
  • Average Net Margin over 5 years is 5.63%, with a median of 5.59% recorded in 2021.
  • Peak YoY movement for Net Margin: tumbled -3958bps in 2021, then surged 296bps in 2023.
  • A 5-year view of Net Margin shows it stood at 12.79% in 2021, then plummeted by -49bps to 6.5% in 2022, then rose by 5bps to 6.85% in 2023, then rose by 6bps to 7.29% in 2024, then increased by 5bps to 7.63% in 2025.
  • Per Business Quant, the three most recent readings for VMD's Net Margin are 7.63% (Q4 2025), 5.01% (Q3 2025), and 5.15% (Q2 2025).